DZ2562A1 - Composition contenant un sensibilisant à l'insuline un secrétagogue d'insuline et un biguanide anti-hyperglycémique. - Google Patents

Composition contenant un sensibilisant à l'insuline un secrétagogue d'insuline et un biguanide anti-hyperglycémique.

Info

Publication number
DZ2562A1
DZ2562A1 DZ980172A DZ980172A DZ2562A1 DZ 2562 A1 DZ2562 A1 DZ 2562A1 DZ 980172 A DZ980172 A DZ 980172A DZ 980172 A DZ980172 A DZ 980172A DZ 2562 A1 DZ2562 A1 DZ 2562A1
Authority
DZ
Algeria
Prior art keywords
insulin
hyperglycemic
biguanide
composition containing
secretagogue
Prior art date
Application number
DZ980172A
Other languages
English (en)
French (fr)
Inventor
Robin Edward Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DZ2562A1 publication Critical patent/DZ2562A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DZ980172A 1997-07-18 1998-07-15 Composition contenant un sensibilisant à l'insuline un secrétagogue d'insuline et un biguanide anti-hyperglycémique. DZ2562A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715295A GB9715295D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
DZ2562A1 true DZ2562A1 (fr) 2003-02-15

Family

ID=10816167

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980172A DZ2562A1 (fr) 1997-07-18 1998-07-15 Composition contenant un sensibilisant à l'insuline un secrétagogue d'insuline et un biguanide anti-hyperglycémique.

Country Status (40)

Country Link
EP (1) EP1001783B1 (es)
JP (2) JP2001510159A (es)
KR (1) KR100671918B1 (es)
CN (1) CN1264303A (es)
AP (1) AP1352A (es)
AR (1) AR016349A1 (es)
AT (1) ATE305790T1 (es)
AU (1) AU8448898A (es)
BG (1) BG64785B1 (es)
BR (1) BR9810445A (es)
CA (1) CA2296653C (es)
CO (1) CO4940420A1 (es)
CY (1) CY1105254T1 (es)
DE (1) DE69831808T2 (es)
DK (1) DK1001783T3 (es)
DZ (1) DZ2562A1 (es)
EA (1) EA003021B1 (es)
ES (1) ES2251093T3 (es)
GB (1) GB9715295D0 (es)
HK (1) HK1028550A1 (es)
HU (1) HUP0003629A3 (es)
ID (1) ID24211A (es)
IL (1) IL134046A0 (es)
IN (1) IN189275B (es)
MA (1) MA24607A1 (es)
MY (1) MY155219A (es)
NO (1) NO325727B1 (es)
NZ (2) NZ511608A (es)
OA (1) OA11279A (es)
PE (1) PE99599A1 (es)
PL (2) PL198017B1 (es)
SA (1) SA98190468B1 (es)
SI (1) SI1001783T1 (es)
SK (1) SK285484B6 (es)
TR (1) TR200000134T2 (es)
TW (1) TW505516B (es)
UA (1) UA70303C2 (es)
UY (1) UY25102A1 (es)
WO (1) WO1999003477A1 (es)
ZA (1) ZA986363B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
AU768994B2 (en) * 1998-11-12 2004-01-15 Smithkline Beecham Plc Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
SE9902918D0 (sv) * 1999-08-13 1999-08-13 Pharmacia & Upjohn Ab Methods for identification of compounds stimulating insulin secretion
MY125516A (en) 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
JP2003514011A (ja) * 1999-11-16 2003-04-15 スミスクライン ビーチャム パブリック リミテッド カンパニー チアゾリジンジオン−塩酸メトホルミンを含む医薬組成物
FR2812547B1 (fr) * 2000-08-04 2002-10-31 Lipha Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
WO2002055009A1 (en) 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
ITFI20010126A1 (it) * 2001-07-09 2003-01-09 Molteni & C Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide
EP1429747A4 (en) * 2001-07-10 2005-01-05 Kos Life Sciences Inc CORE FORMULATION WITH PIOGLITAZONE HYDROCHLORIDE AND A BIGUANIDE
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
UA80991C2 (en) 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
NZ546337A (en) 2003-10-31 2009-03-31 Takeda Pharmaceutical Solid preparation comprising an insulin sensitizer such as pioglitazone hydrochloride, an insulin secretagogue such as glimepiride and a polyoxyethylene sorbitan fatty acid ester such as Polysorbate 80
MXPA05010977A (es) * 2005-10-12 2007-04-11 Abdala Leopoldo Espinosa Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus.
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
CN101417130B (zh) * 2007-10-22 2010-10-06 鲁南制药集团股份有限公司 一种治疗ⅱ型糖尿病及其并发症的药物组合物
WO2019078663A2 (ko) * 2017-10-20 2019-04-25 주식회사 노브메타파마 아연염, 시클로-히스프로 및 항당뇨 약물을 유효성분으로 함유하는 당뇨병 예방 또는 치료용 약학적 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−2,4−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5900435A (en) * 1991-08-26 1999-05-04 Pharmacia & Upjohn Company Composition, food product and uses of 3-guanidinopropionic acid
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
UA67743C2 (uk) * 1997-06-18 2004-07-15 Смітклайн Бічам П.Л.С. Фармацевтична композиція, що містить тіазолідиндіон і сульфонілсечовину, для лікування діабету

Also Published As

Publication number Publication date
KR100671918B1 (ko) 2007-01-22
AP2000001733A0 (en) 2000-03-31
BG64785B1 (bg) 2006-04-28
TR200000134T2 (tr) 2000-09-21
ATE305790T1 (de) 2005-10-15
CA2296653A1 (en) 1999-01-28
AU8448898A (en) 1999-02-10
ID24211A (id) 2000-07-13
NZ511608A (en) 2002-12-20
IN189275B (es) 2003-01-25
GB9715295D0 (en) 1997-09-24
NO325727B1 (no) 2008-07-07
OA11279A (en) 2003-07-31
WO1999003477A1 (en) 1999-01-28
BG104135A (en) 2000-10-31
SK285484B6 (sk) 2007-02-01
PL198017B1 (pl) 2008-05-30
ES2251093T3 (es) 2006-04-16
ZA986363B (en) 2000-01-17
DE69831808D1 (de) 2006-02-16
TW505516B (en) 2002-10-11
AR016349A1 (es) 2001-07-04
NO20000228L (no) 2000-01-17
DK1001783T3 (da) 2006-02-06
HUP0003629A2 (hu) 2001-07-30
PE99599A1 (es) 1999-12-18
EA200000139A1 (ru) 2000-06-26
CO4940420A1 (es) 2000-07-24
SK592000A3 (en) 2000-09-12
PL338126A1 (en) 2000-09-25
UA70303C2 (uk) 2004-10-15
KR20010021947A (ko) 2001-03-15
HK1028550A1 (en) 2001-02-23
MY155219A (en) 2015-09-30
JP2001510159A (ja) 2001-07-31
SA98190468B1 (ar) 2007-01-20
JP2005213273A (ja) 2005-08-11
NZ501164A (en) 2001-06-29
EA003021B1 (ru) 2002-12-26
IL134046A0 (en) 2001-04-30
HUP0003629A3 (en) 2003-04-28
AP1352A (en) 2004-12-24
MA24607A1 (fr) 1999-04-01
CA2296653C (en) 2007-10-02
EP1001783A1 (en) 2000-05-24
DE69831808T2 (de) 2006-07-06
NO20000228D0 (no) 2000-01-17
CY1105254T1 (el) 2010-03-03
EP1001783B1 (en) 2005-10-05
CN1264303A (zh) 2000-08-23
BR9810445A (pt) 2000-09-05
UY25102A1 (es) 2000-12-29
PL197844B1 (pl) 2008-05-30
SI1001783T1 (sl) 2006-02-28

Similar Documents

Publication Publication Date Title
DZ2562A1 (fr) Composition contenant un sensibilisant à l'insuline un secrétagogue d'insuline et un biguanide anti-hyperglycémique.
FR2719997B1 (fr) Dispositif à timbre de délivrance transcutanée d'insuline.
DE69132536D1 (de) Verbindungslose ATM-Datendienste
FR2717250B1 (fr) Système d'injection à prémélange.
BR9806060B1 (pt) composto n-[(aminoiminometil ou aminometil) fenil] propil amida, e, composição farmacêutica.
EP0621714A3 (en) Platform for information services.
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
DZ2937A1 (fr) Compositions nouvelles de sensibilidants à l'insuline.
DZ2563A1 (fr) Composition contenant un sensibilisant à l'insuline un secrétagogue d'insuline et un biguanide anti-hyperglycérnique inhibiteur d'alpha-glucosidase.
NO964684D0 (no) 2-(aminometyl)-3,4,7,9-tetrahydro-2H-pyrano-[2,3-eÅ indol-8-oner og derivater
MA23426A1 (fr) Composition fongicide a base d'iprodione et d'un compose triazole.
FR2719040B1 (fr) Nouveaux agents tensio-actifs à base d'éthers polyoxy-éthylénique-propylénique.
NO20000114L (no) 2,4,4-trisubstituerte 1,3-dioksolan-antifungale midler
DE69022560D1 (de) N,N'-hydrocarbylen-bis-(N-hals)-substituierte Amidhydrazide.
IT1316050B1 (it) Polinitramina, suo procedimento di sintesi e composizionipirotecniche.
ITTO950543A0 (it) Apparecchio di dosatura, e cartuccia utilizzata in questo apparecchio.
FR2704343B1 (fr) Machine à affranchir en deux parties.
FR2727965B1 (fr) 4,4'-(phenylenediisopropyl )-bis- (2.6-dialkylphenylisocyanates)
IT1274915B (it) Unita' modulare per il contenimento di fiale, fialoidi e similari.
ITMI920989A0 (it) Macchina torsionatrice, in particolare per la fabbricazione di molle a torsione, semplici e doppie, ad elevata flessibilita' di impiego.
FR2705815B1 (fr) Borne d'informations sensitive.
TH31470A (th) พิโรลที่ถูกแทนที่
ES1037082Y (es) "expositor portatil perfeccionado".
KR960004331U (ko) 명함 케이스
KR950022994U (ko) 명함케이스